Chewy Q1 FY2026 earnings showed 7.7% revenue growth, stronger adjusted EBITDA margins and Autoship momentum, but softer pet spending pressured guidance.

Key Highlights

  • Chewy Q1 net sales rose 7.7% to $3.36 billion.
  • Adjusted EBITDA margin expanded 130 basis points to 7.5%.
  • Management lowered full-year sales guidance due to softer consumer trends.

Chewy delivered a mixed first-quarter report for fiscal 2026. Revenue growth remained positive, profitability improved sharply and Autoship continued to strengthen the company’s recurring sales base. Yet management also signalled a more cautious consumer backdrop, with pressure on discretionary attachment and premiumization weighing on the growth outlook.

Chewy is a U.S.-based online pet products and pet healthcare platform, offering food, supplies, prescriptions, veterinary services and recurring Autoship deliveries for pet owners. Its model is built around repeat purchases, customer loyalty and expanding share of wallet across the pet care ecosystem.

For Chewy, Inc. (NYSE: CHWY), the quarter was therefore less about whether the business is profitable and more about whether margin expansion can offset slower pet category spending.

Revenue Growth Remained Resilient

Chewy reported first-quarter net sales of $3.36 billion, up 7.7% from the prior-year period. The result was broadly in line with market expectations and reflected continued share gains in the pet category.

Active customers increased 3.6% year over year to 21.5 million, while net sales per active customer reached $597. Autoship customer sales rose 10.5% to $2.83 billion and represented 84.4% of total net sales.

That Autoship mix remains central to Chewy’s investment case. It gives the company a recurring revenue profile in a category driven by repeat pet food, pharmacy and wellness purchases. In a weaker consumer environment, that recurring base provides more stability than a purely discretionary retail model.

EPS Optics Need Careful Reading

Chewy reported GAAP diluted EPS of $0.23, compared with $0.15 a year earlier. Adjusted diluted EPS was $0.43, up from $0.35 last year.

This distinction matters because some market screens may show an EPS miss if they compare GAAP EPS against an adjusted estimate. On an adjusted basis, Chewy’s earnings performance was stronger, supported by higher adjusted net income and adjusted EBITDA.

Adjusted net income rose to $179.9 million, while net income increased to $94.8 million. The gap between GAAP and adjusted figures mainly reflects share-based compensation, transaction-related costs and other adjustments.

Margins Were the Strongest Part of the Quarter

Chewy’s gross margin improved 50 basis points year over year to 30.1%. Adjusted EBITDA rose 31.3% to $253.1 million, while adjusted EBITDA margin expanded 130 basis points to 7.5%.

This was the clearest positive in the report. Chewy is growing earnings faster than revenue, helped by Sponsored Ads, product mix, supply chain efficiency, operating discipline and early AI-enabled productivity gains.

Management reiterated its long-term target of reaching a 10% adjusted EBITDA margin over time. Importantly, the company said its margin expansion does not depend on outsized pet category growth or heavy pricing inflation, but on structural drivers such as advertising, automation, health mix and fulfillment leverage.

Guidance Shows Consumer Caution

Despite the margin strength, Chewy lowered its full-year fiscal 2026 net sales outlook to $13.40 billion to $13.55 billion, representing growth of 6.3% to 7.5%.

Management said the consumer environment weakened late in the quarter. The pressure is showing up in slower premiumization and weaker discretionary attachment, rather than a breakdown in recurring consumables or Autoship demand.

Chewy maintained full-year adjusted EBITDA margin guidance of 6.6% to 6.8%, which implies roughly $900 million of adjusted EBITDA at the midpoint. This suggests management still expects earnings durability even with more cautious sales assumptions.

Vet Care Expands the Long-Term Growth Platform

Chewy continues to expand its health and veterinary strategy. The company closed the SmartPak acquisition in Q1 and completed the Modern Animal acquisition shortly after quarter-end.

Modern Animal adds 29 clinics, while Chewy expects to exit fiscal 2026 with roughly 60 veterinary clinics. Management said Chewy Vet Care customers are attractive because about 40% are new to Chewy and tend to generate higher first-year spending.

This strategy expands Chewy beyond online pet retail into a broader pet healthcare ecosystem. The opportunity is large, but execution risk is also higher, given clinic integration, labor availability and operating complexity.

AI and Sponsored Ads Support the Margin Story

Chewy is also leaning into AI and Sponsored Ads as structural margin drivers. Management said AI is being used across customer service, pharmacy operations, fulfillment and marketing workflows, with expected low tens of millions of dollars in efficiency benefits during fiscal 2026 and a larger ramp in 2027.

Sponsored Ads remain another margin lever. The business benefits from Chewy’s large customer base, recurring traffic and strong pet brand relationships. Over time, advertising could help lift profitability without requiring the company to rely only on product pricing or higher sales volume.

Conclusion

Chewy’s Q1 FY2026 earnings showed a business with improving profitability, strong Autoship retention and growing healthcare ambitions. The concern is not margin execution, which remains strong, but the pace of revenue growth as pet consumers become more selective.

If Chewy can sustain share gains while expanding health, Sponsored Ads and AI efficiencies, CHWY may retain a credible long-term growth story. Near term, however, valuation will likely depend on whether softer premiumization is temporary or a more persistent pressure on net sales per customer.